Weight loss medications approved by the FDA include GLP-1 receptor agonist drugs, such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
In a clinical or wellness setting, BPC-157 therapy is provided as part of a provider-supervised treatment plan focused on recovery support, injury management, and overall physical wellness
Experiencing increase in energy but no weight loss yet You guys are great but this seems to sting for a while at injection site for a half hour or so and not sure if that is common
2050 mcg once daily subcutaneously, titrated upward gradually across an 812 week course
Your safety is our top priority
I highly recommend this product for its reliability and the great service from the company.